Mayne Pharma Half Year Result - MYX meets expectations as Doryx delivers


Pharmaceutical company, Mayne Pharma Group (MYX), reported a near quadrupling in Net Profit After Tax (NPAT) for the first half-year of 2016 to $19.2 million which was in line with consensus estimates For more Reporting Season coverage, please visit (VIEW LINK)


CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...

mayne pharma myx


Please sign in to comment on this wire.